chr19-18155941-A-AGGACCTGGAGCTGCTGCCCGGCGAC
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The ENST00000222254.13(PIK3R2):c.64_88dup(p.Val30GlyfsTer48) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
PIK3R2
ENST00000222254.13 frameshift
ENST00000222254.13 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.44
Genes affected
PIK3R2 (HGNC:8980): (phosphoinositide-3-kinase regulatory subunit 2) Phosphatidylinositol 3-kinase (PI3K) is a lipid kinase that phosphorylates phosphatidylinositol and similar compounds, creating second messengers important in growth signaling pathways. PI3K functions as a heterodimer of a regulatory and a catalytic subunit. The protein encoded by this gene is a regulatory component of PI3K. Three transcript variants, one protein coding and the other two non-protein coding, have been found for this gene. [provided by RefSeq, Apr 2019]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 21 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIK3R2 | NM_005027.4 | c.64_88dup | p.Val30GlyfsTer48 | frameshift_variant | 2/16 | ENST00000222254.13 | NP_005018.2 | |
PIK3R2 | NR_073517.2 | n.619_643dup | non_coding_transcript_exon_variant | 2/16 | ||||
PIK3R2 | NR_162071.1 | n.619_643dup | non_coding_transcript_exon_variant | 2/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIK3R2 | ENST00000222254.13 | c.64_88dup | p.Val30GlyfsTer48 | frameshift_variant | 2/16 | 1 | NM_005027.4 | ENSP00000222254 | P1 | |
PIK3R2 | ENST00000617130.5 | c.64_88dup | p.Val30GlyfsTer48 | frameshift_variant, NMD_transcript_variant | 2/15 | 1 | ENSP00000477864 | |||
PIK3R2 | ENST00000426902.5 | c.64_88dup | p.Val30GlyfsTer48 | frameshift_variant, NMD_transcript_variant | 1/15 | 2 | ENSP00000395636 | |||
PIK3R2 | ENST00000617642.2 | c.64_88dup | p.Val30GlyfsTer48 | frameshift_variant, NMD_transcript_variant | 2/14 | 5 | ENSP00000484714 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jan 28, 2020 | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at